Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1993-6-29
pubmed:abstractText
The cutaneous T cell lymphomas (CTCL), typified by mycosis fungoides, and several chronic T cell mediated dermatoses are characterized by the migration of T lymphocytes into the epidermis (epidermotropism). Alternatively, other types of cutaneous inflammation (malignant cutaneous B cell lymphoma, CBCL, or lymphocytoma cutis, non-malignant T or B cell type) do not show evidence of epidermotropism. This suggests that certain T lymphocyte subpopulations are able to interact with and penetrate the epidermal basement membrane. We show here that T lymphocytes derived from patients with CTCL (HUT 78 or HUT 102 cells), adhere to the detergent-insoluble extracellular matrix prepared from cultured basal keratinocytes (HFK ECM). HUT cell adhesion to HFK ECM was inhibitable with monoclonal antibodies (mAbs) directed to the alpha 3 (P1B5) or beta 1 (P4C10) integrin receptors, and could be up-regulated by an activating anti-beta 1 mAb (P4G11). An inhibitory mAb, P3H9-2, raised against keratinocytes identified epiligrin as the ligand for alpha 3 beta 1 positive T cells in HFK ECM. Interestingly, two lymphocyte populations could be clearly distinguished relative to expression of alpha 3 beta 1 by flow cytometry analysis. Lymphokine activated killer cells, alloreactive cytotoxic T cells and T cells derived from patients with CTCL expressed high levels of alpha 3 beta 1 (alpha 3 beta 1high). Non-adherent peripheral blood mononuclear cells, acute T or B lymphocytic leukemias, or non-cutaneous T or B lymphocyte cell lines expressed low levels of alpha 3 beta 1 (alpha 3 beta 1low). Resting PBL or alpha 3 beta 1low T or B cell lines did not adhere to HFK ECM or purified epiligrin. However, adhesion to epiligrin could be up-regulated by mAbs which activate the beta 1 subunit indicating that alpha 3 beta 1 activity is a function of expression and affinity. In skin derived from patients with graft-vs.-host (GVH) disease, experimentally induced delayed hypersensitivity reactions, and CTCL, the infiltrating T cells could be stained with mAbs to alpha 3 or beta 1 and were localized in close proximity to the epiligrin-containing basement membrane. Infiltrating lymphocytes in malignant cutaneous B disease (CBCL) did not express alpha 3 beta 1 by immunohistochemical techniques and did not associate with the epidermal basement membrane. The present findings clearly define a function for alpha 3 beta 1 in T cells and strongly suggest that alpha 3 beta 1 interaction with epiligrin may be involved in the pathogenesis of cutaneous inflammation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1315686, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1378720, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1401088, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1411902, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1439808, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1517226, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1527019, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1530947, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1531944, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1555235, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1656130, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1670850, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1689734, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1691191, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1693467, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1705666, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1705667, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1860885, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-1986004, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2032285, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2119632, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2138122, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2153105, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2165129, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2194672, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2232712, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2269668, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2455685, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2477710, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2527858, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2530239, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2538453, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2808408, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2822727, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2846588, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2965180, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2973567, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2974420, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-2978786, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-3079259, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-6244013, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-6644024, http://linkedlifedata.com/resource/pubmed/commentcorrection/8501119-6975346
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0021-9525
pubmed:author
pubmed:issnType
Print
pubmed:volume
121
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1141-52
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
More...